Axial to Centrifugal Continuous Flow LVAD Pump Exchange Using Minimally Invasive Technique

Amit A. Pawale; Ariel Farkash; Dimosthenis Pandis; Anelechi C. Anyanwu

doi:10.1097/imi.0000000000000429

Axial to Centrifugal Continuous Flow LVAD Pump Exchange Using Minimally Invasive Technique

Amit A. Pawale, Ariel Farkash, Dimosthenis Pandis, Anelechi C. Anyanwu

Division of Cardiothoracic Surgery

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Driveline or device infection may complicate left ventricular assist device implants, and only curative option may be pump exchange. Replacement with similar device may be liable to reinfection, because pump configuration is such that the new device and driveline may partly lie within the pocket of the previous pump. One approach to overcome this is using a different pump design such that the new pump would lie in a different location from the old pump. We describe treatment of severe HeartMate II (Abbott, [St Jude Thoratec Corp], Pleasanton, CA USA) left ventricular assist device infection by minimally invasive exchange to an intrapericardial HVAD (HeartWare International, Inc, Framingham, MA USA) left ventricular assist device.

Original language	English
Pages (from-to)	496-498
Number of pages	3
Journal	Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
Volume	12
Issue number	6
DOIs	https://doi.org/10.1097/imi.0000000000000429
State	Published - Nov 1 2017

Keywords

Left ventricular assist device
Minimally invasive cardiac surgery
Pump exchange

Access to Document

10.1097/imi.0000000000000429

Cite this

@article{111b850010c14262916c0d927c17fb40,

title = "Axial to Centrifugal Continuous Flow LVAD Pump Exchange Using Minimally Invasive Technique",

abstract = "Driveline or device infection may complicate left ventricular assist device implants, and only curative option may be pump exchange. Replacement with similar device may be liable to reinfection, because pump configuration is such that the new device and driveline may partly lie within the pocket of the previous pump. One approach to overcome this is using a different pump design such that the new pump would lie in a different location from the old pump. We describe treatment of severe HeartMate II (Abbott, [St Jude Thoratec Corp], Pleasanton, CA USA) left ventricular assist device infection by minimally invasive exchange to an intrapericardial HVAD (HeartWare International, Inc, Framingham, MA USA) left ventricular assist device.",

keywords = "Left ventricular assist device, Minimally invasive cardiac surgery, Pump exchange",

author = "Pawale, {Amit A.} and Ariel Farkash and Dimosthenis Pandis and Anyanwu, {Anelechi C.}",

note = "Publisher Copyright: {\textcopyright} 2017 International Society for Minimally Invasive Cardiothoracic Surgery.",

year = "2017",

month = nov,

day = "1",

doi = "10.1097/imi.0000000000000429",

language = "English",

volume = "12",

pages = "496--498",

journal = "Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery",

issn = "1556-9845",

number = "6",

}

TY - JOUR

T1 - Axial to Centrifugal Continuous Flow LVAD Pump Exchange Using Minimally Invasive Technique

AU - Pawale, Amit A.

AU - Farkash, Ariel

AU - Pandis, Dimosthenis

AU - Anyanwu, Anelechi C.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Driveline or device infection may complicate left ventricular assist device implants, and only curative option may be pump exchange. Replacement with similar device may be liable to reinfection, because pump configuration is such that the new device and driveline may partly lie within the pocket of the previous pump. One approach to overcome this is using a different pump design such that the new pump would lie in a different location from the old pump. We describe treatment of severe HeartMate II (Abbott, [St Jude Thoratec Corp], Pleasanton, CA USA) left ventricular assist device infection by minimally invasive exchange to an intrapericardial HVAD (HeartWare International, Inc, Framingham, MA USA) left ventricular assist device.

AB - Driveline or device infection may complicate left ventricular assist device implants, and only curative option may be pump exchange. Replacement with similar device may be liable to reinfection, because pump configuration is such that the new device and driveline may partly lie within the pocket of the previous pump. One approach to overcome this is using a different pump design such that the new pump would lie in a different location from the old pump. We describe treatment of severe HeartMate II (Abbott, [St Jude Thoratec Corp], Pleasanton, CA USA) left ventricular assist device infection by minimally invasive exchange to an intrapericardial HVAD (HeartWare International, Inc, Framingham, MA USA) left ventricular assist device.

KW - Left ventricular assist device

KW - Minimally invasive cardiac surgery

KW - Pump exchange

UR - http://www.scopus.com/inward/record.url?scp=85052332065&partnerID=8YFLogxK

U2 - 10.1097/imi.0000000000000429

DO - 10.1097/imi.0000000000000429

M3 - Article

C2 - 29206805

AN - SCOPUS:85052332065

SN - 1556-9845

VL - 12

SP - 496

EP - 498

JO - Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

JF - Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

IS - 6

ER -

Axial to Centrifugal Continuous Flow LVAD Pump Exchange Using Minimally Invasive Technique

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this